🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Total endovascular repair of the aortic arch represents a promising option ...
Status
Completed
Location
CHU Saint-Etienne
Start Date
2019-01-01
Trial ID
NCT04244188
Treatments Being Tested
This is a monocentric, retrospective, non-interventional study. The main ob...
Status
Unknown
Location
Centre AMP Maternité Régionale de Nancy
Start Date
2023-03-01
Trial ID
NCT06163079
Treatments Being Tested
Once the pericardium is closed, there is no information on the hemodynamics...
Status
Completed
Location
Chu Saint-Etienne
Start Date
2022-01-01
Trial ID
NCT06181565
Treatments Being Tested
Lumbar plexus block is described as a difficult block, thus requiring exper...
Status
Completed
Location
CHU Saint-Etienne
Start Date
2019-01-01
Trial ID
NCT05760963
Treatments Being Tested
Accidental dural puncture is an uncommon complication of epidural analgesia...
Status
Completed
Location
CHU Saint-Etienne
Start Date
2022-03-01
Trial ID
NCT05910086
Treatments Being Tested
The pathophysiology of the most common corneal endothelial dystrophies (Fuc...
Status
Completed
Location
Chu Saint-Etienne
Start Date
2019-08-01
Trial ID
NCT03974230
Treatments Being Tested
The actual COVID-19 epidemy is an unprecedented healthcare problem. Althoug...
Status
Unknown
Location
Intensive care units attached to the Hospices Civils de Lyon (HCL)
Start Date
2020-04-01
Trial ID
NCT04459975
Treatments Being Tested
Pupillary diameter monitoring is currently used routinely for assessment of...
Status
Completed
Location
Chu Saint-Etienne
Start Date
2019-04-01
Trial ID
NCT03867955
Treatments Being Tested
Rupture of Anterior Cruciate Ligament (ACL) is a common pathology, but is s...
Status
Recruiting
Location
Chu Saint-Etienne
Start Date
2021-03-01
Trial ID
NCT04781920
Treatments Being Tested
Vismodegib (ERIVEDGE®) at the standard dose of 150 mg/day orally is indicat...
Status
Completed
Location
Chu de Bordeaux
Start Date
2018-09-03
Trial ID
NCT03610022
Treatments Being Tested